Pilot Projects for ME/CFS Research supports Cornell researchers, including new investigators and trainees, in pilot studies that expand ME/CFS research and foster new collaborations.
Funder: Cornell University
Due Dates: October 8, 2026, at 5 PM ET (Application) | October 15, 2026 (Award notification by) | December 15, 2027 (Progress report)
Funding Amounts: Up to $30,000 per project; up to three awards; stated funding term November 1, 2026–March 31, 2027
Summary: Supports pilot studies on ME/CFS to expand research at Cornell and encourage new investigators and collaborations.
Key Information: Principal investigators must hold appointments on Cornell’s Ithaca campus; Weill Cornell Medicine researchers may participate as co-investigators.
The Cornell Center for Enervating NeuroImmune Disease supports pilot research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Funded through Cornell University and the NIH-funded Cornell ME/CFS Center award (U54AI178855), the program aims to grow ME/CFS research at Cornell and foster new collaborations. Applications from new investigators and trainees, including graduate students and postdoctoral researchers, are particularly encouraged.
The program supports research expenses, core facility charges, and non-faculty personnel for pilot studies. It encourages collaborations with current Cornell ME/CFS researchers and considers the potential for subsequent extramural funding. The Center’s broader mission is to identify ME/CFS causes, biomarkers, and pathophysiology to advance prevention and effective treatments.